Indirect evidence suggests that men did not understand or appreciate that the effect of PSA on increasing the chance of prostate cancer diagnosis in and of itself should not always be considered a benefit of screening, because of overdiagnosis. This evidence concerns the gene KLK3 and prostate cancer.